Pfizer Announces Results From Two Phase 3 TRUMENBA Studies At The European Society For Paediatric Infectious Diseases Meeting
Pfizer Inc announced results of two Phase 3 studies demonstrating the immunogenicity of TRUMENBA® (Meningococcal Group B Vaccine) against invasive meningococcal B (MnB)...
Biogen and Abbvie Receive Positive Opinion From The CHMP on ZINBRYTA™ (daclizumab) For Treatment Of Multiple Sclerosis
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of...
Inovio Signs Collaborative Research Agreements
Inovio Signs Collaborative Research Agreements With Wistar Institute for DNA-based Immunotherapies and VaccinesNew Agreement Follows Dr. David B. Weiner’s Move to Wistar from...
AstraZeneca’s potential medicine for neuromyelitis optica receives FDA Orphan Drug Designation
AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration (FDA) has granted Orphan...
Orexigen and Takeda Jointly Announce Orexigen’s Acquisition of All Rights to CONTRAVE® in United States
Acquisition provides Orexigen ownership of CONTRAVE in nearly all major global markets Takeda Moves to Strengthen Focus on Recent Launches Orexigen Therapeutics, Inc. (Nasdaq:...
NEX China 2016 to Set Sail by the “Healthy and Natural” Wind
NEX China 2016, hosted by UBM EMEA and China Chamber of Commerce of Medicines &Health Products Importers & Exporters and co-organized by UBM Sinoexpo,...
ICSE China 2016 – A gala event for pharma CRO & CMO industry
ICSE China 2016, hosted by UBM EMEA and China Chamber of Commerce of Medicines & Health Products Importers & Exporters and co-organized by UBM...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...